| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | David A. Savitz | Q5230516 |
| Kyle Steenland | Q22089123 | ||
| P2093 | author name string | Tony Fletcher | |
| P2860 | cites work | Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha | Q23914416 |
| Serum perfluorooctanoic acid and hepatic enzymes, lipoproteins, and cholesterol: A study of occupationally exposed men | Q24169422 | ||
| The relationship between birth weight, gestational age and perfluorooctanoic acid (PFOA)-contaminated public drinking water | Q24623988 | ||
| Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey | Q24624507 | ||
| Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources | Q24626351 | ||
| Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia | Q24633826 | ||
| Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population | Q24633846 | ||
| Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth | Q24647791 | ||
| Prenatal exposure to perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS) and maternally reported developmental milestones in infancy | Q24651358 | ||
| The C8 health project: design, methods, and participants | Q24652791 | ||
| Do perfluoroalkyl compounds impair human semen quality? | Q24657367 | ||
| Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort | Q24680484 | ||
| Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth | Q24680500 | ||
| Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000 | Q24680576 | ||
| Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy. | Q24815415 | ||
| Central administration of perfluorooctanoic acid inhibits cutaneous inflammation | Q28181520 | ||
| Serum concentrations of 11 polyfluoroalkyl compounds in the u.s. population: data from the national health and nutrition examination survey (NHANES). | Q31109567 | ||
| Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats | Q32062110 | ||
| A reexamination of the PPAR-alpha activation mode of action as a basis for assessing human cancer risks of environmental contaminants | Q33569334 | ||
| Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with uric acid among adults with elevated community exposure to PFOA. | Q33702676 | ||
| Plasma cholecystokinin and hepatic enzymes, cholesterol and lipoproteins in ammonium perfluorooctanoate production workers | Q33924739 | ||
| Perfluorinated compounds--exposure assessment for the general population in Western countries | Q34012353 | ||
| Investigation of the associations between low-dose serum perfluorinated chemicals and liver enzymes in US adults | Q34088146 | ||
| The toxicology of perfluorooctanoate | Q34343282 | ||
| Multiple organic anion transporters contribute to net renal excretion of uric acid | Q34470733 | ||
| Congenital anomalies, labor/delivery complications, maternal risk factors and their relationship with perfluorooctanoic acid (PFOA)-contaminated public drinking water | Q34570340 | ||
| Community exposure to perfluorooctanoate: relationships between serum levels and certain health parameters | Q34571004 | ||
| Perfluoroalkyl acids: a review of monitoring and toxicological findings | Q34630884 | ||
| Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers | Q34680365 | ||
| Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples. | Q34799750 | ||
| Maternal levels of perfluorinated chemicals and subfecundity | Q34931926 | ||
| Perfluorooctanoate and perfluorooctanesulfonate plasma levels and risk of cancer in the general Danish population | Q34974681 | ||
| Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome | Q34998270 | ||
| Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant. | Q35008916 | ||
| Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 Health Project | Q35049761 | ||
| PPARalpha agonist-induced rodent tumors: modes of action and human relevance | Q35631058 | ||
| Perfluorooctanoic acid-induced immunomodulation in adult C57BL/6J or C57BL/6N female mice | Q36633073 | ||
| Biomonitoring of perfluorinated compounds in children and adults exposed to perfluorooctanoate-contaminated drinking water | Q36633077 | ||
| Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial | Q37197711 | ||
| Predictors of PFOA levels in a community surrounding a chemical plant. | Q37278944 | ||
| Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives | Q37476192 | ||
| The association between serum uric acid level and long-term incidence of hypertension: Population-based cohort study | Q39770827 | ||
| Roles of organic anion transporters in the renal excretion of perfluorooctanoic acid. | Q39997446 | ||
| Guest editorial: biomarkers of perfluorinated chemicals and birth weight | Q42714063 | ||
| A map of European emissions and concentrations of PFOS and PFOA. | Q43226207 | ||
| Maternal exposure to perfluorinated acids and fetal growth | Q43253111 | ||
| Ammonium perfluorooctanoate production and occupational mortality | Q43268281 | ||
| A cross-sectional analysis of type II diabetes in a community with exposure to perfluorooctanoic acid (PFOA). | Q43279026 | ||
| Estimation and validation of biomarker-based exposures for historical ammonium perfluorooctanoate | Q43554786 | ||
| Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months | Q44128201 | ||
| Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations | Q44379609 | ||
| Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries | Q45087717 | ||
| Ischaemic heart disease mortality study among workers with occupational exposure to ammonium perfluorooctanoate. | Q45954303 | ||
| Exploratory assessment of perfluorinated compounds and human thyroid function. | Q46023600 | ||
| Thirty years of medical surveillance in perfluooctanoic acid production workers | Q46118153 | ||
| Evidence for the involvement of xenobiotic-responsive nuclear receptors in transcriptional effects upon perfluoroalkyl acid exposure in diverse species. | Q46151663 | ||
| Fetal growth indicators and perfluorinated chemicals: a study in the Danish National Birth Cohort | Q46442964 | ||
| Evaluation of the immune system in rats and mice administered linear ammonium perfluorooctanoate | Q46535824 | ||
| Retrospective cohort mortality study of workers in a polymer production plant including a reference population of regional workers | Q46608357 | ||
| Perfluorooctane surfactants in waste waters, the major source of river pollution. | Q46740568 | ||
| Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or APFO) as part of a general health survey in a cohort of occupationally exposed workers | Q46901755 | ||
| Comparative responses of rats and mice exposed to linear/branched, linear, or branched ammonium perfluorooctanoate (APFO). | Q46920851 | ||
| Preliminary evidence of a decline in perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations in American Red Cross blood donors. | Q50706897 | ||
| Negative bias from analog methods used in the analysis of free thyroxine in rat serum containing perfluorooctanesulfonate (PFOS). | Q51760615 | ||
| Perfluoroalkyl acids and related chemistries--toxicokinetics and modes of action. | Q53225736 | ||
| Serum perfluorooctane sulfonate and hepatic and lipid clinical chemistry tests in fluorochemical production employees | Q73005772 | ||
| Effects of peroxisome proliferators on the thymus and spleen of mice | Q73223344 | ||
| An epidemiologic investigation of reproductive hormones in men with occupational exposure to perfluorooctanoic acid | Q74802865 | ||
| Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers | Q80554158 | ||
| Longitudinal study of serum lipids and liver enzymes in workers with occupational exposure to ammonium perfluorooctanoate | Q80785516 | ||
| Health risks in infants associated with exposure to perfluorinated compounds in human breast milk from Zhoushan, China | Q83829339 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lipid | Q11367 |
| environmental monitoring | Q1749732 | ||
| hydrocarbon | Q43648 | ||
| epidemiology | Q133805 | ||
| carboxylic acid | Q134856 | ||
| P304 | page(s) | 1100-8 | |
| P577 | publication date | 2010-08-01 | |
| P1433 | published in | Environmental Health Perspectives | Q1345904 |
| P1476 | title | Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA) | |
| P478 | volume | 118 |
| Q41559585 | A cohort incidence study of workers exposed to perfluorooctanoic acid (PFOA). |
| Q93336503 | A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFASs) and present understanding of health effects |
| Q42714327 | A species difference in the peroxisome proliferator-activated receptor α-dependent response to the developmental effects of perfluorooctanoic acid. |
| Q47234737 | An integrated approach with the zebrafish model for biomonitoring of municipal wastewater effluent and receiving waters |
| Q28545810 | Association between perfluorinated compound exposure and miscarriage in Danish pregnant women |
| Q50555508 | Association between perfluorinated compounds and time to pregnancy in a prospective cohort of Danish couples attempting to conceive. |
| Q28394440 | Association between perfluoroalkyl acids and kidney function in a cross-sectional study of adolescents |
| Q55331831 | Association between perfluoroalkyl substances exposure and thyroid function in adults: A meta-analysis. |
| Q36618735 | Association between plasma PFOA and PFOS levels and total cholesterol in a middle-aged Danish population |
| Q58080051 | Associations between longitudinal serum perfluoroalkyl substance (PFAS) levels and measures of thyroid hormone, kidney function, and body mass index in the Fernald Community Cohort |
| Q53105752 | Associations between perfluoroalkyl compounds and immune and clinical chemistry parameters in highly exposed bottlenose dolphins (Tursiops truncatus). |
| Q92605021 | Associations of Perfluoroalkyl substances with blood lipids and Apolipoproteins in lipoprotein subspecies: the POUNDS-lost study |
| Q99405769 | Astaxanthin reduces perfluorooctanoic acid cytotoxicity in Saccharomyces cerevisiae |
| Q38161679 | Behaviour and fate of perfluoroalkyl and polyfluoroalkyl substances (PFASs) in drinking water treatment: a review |
| Q33654524 | Biomarker-based calibration of retrospective exposure predictions of perfluorooctanoic acid. |
| Q59806739 | Breast cancer risk and serum levels of per- and poly-fluoroalkyl substances: a case-control study nested in the California Teachers Study |
| Q28387100 | Causal inference considerations for endocrine disruptor research in children's health |
| Q34296310 | Changing interpretation of human health risks from perfluorinated compounds |
| Q34307019 | Cohort mortality study of workers exposed to perfluorooctanoic acid |
| Q36856193 | Cross-sectional association between polyfluoroalkyl chemicals and cognitive limitation in the National Health and Nutrition Examination Survey |
| Q56795452 | Delayed discovery, dissemination, and decisions on intervention in environmental health: a case study on immunotoxicity of perfluorinated alkylate substances |
| Q37072630 | Design, methods, and population for a study of PFOA health effects among highly exposed mid-Ohio valley community residents and workers |
| Q64278282 | Dose Effects of Ammonium Perfluorooctanoate on Lipoprotein Metabolism in APOE*3-Leiden.CETP Mice |
| Q45972435 | Early life exposure to per- and polyfluoroalkyl substances and mid-childhood lipid and alanine aminotransferase levels. |
| Q93000711 | Early pregnancy serum levels of perfluoroalkyl substances and risk of preeclampsia in Swedish women |
| Q51715142 | Effect of surfactants on the degradation of perfluorooctanoic acid (PFOA) by ultrasonic (US) treatment. |
| Q28079540 | Effects of Environmental Exposures on Fetal and Childhood Growth Trajectories |
| Q50458119 | Effects of chronic perfluorooctanoic acid (PFOA) at low concentration on morphometrics, gene expression, and fecundity in zebrafish (Danio rerio). |
| Q24633469 | Endocrine disrupting properties of perfluorooctanoic acid |
| Q26827830 | Environmental chemicals and DNA methylation in adults: a systematic review of the epidemiologic evidence |
| Q47929679 | Environmental chemicals and preterm birth: Biological mechanisms and the state of the science. |
| Q37831851 | Environmental neurotoxicants and developing brain |
| Q91963302 | Environmental risk factors for liver cancer and nonalcoholic fatty liver disease |
| Q30863550 | Estimating common parameters of lognormally distributed environmental and biomonitoring data: harmonizing disparate statistics from publications |
| Q60126454 | Evaluation and Management Strategies for Per- and Polyfluoroalkyl Substances (PFASs) in Drinking Water Aquifers: Perspectives from Impacted U.S. Northeast Communities |
| Q59217192 | Exposure to Perfluoroalkyl Substances and Sperm DNA Global Methylation in Arctic and European Populations |
| Q28383912 | Exposure to perfluoroalkyl acids and markers of kidney function among children and adolescents living near a chemical plant |
| Q46319568 | Exposure to polybrominated diphenyl ethers and perfluoroalkyl substances in a remote population of Alaska Natives. |
| Q30513661 | High-performance metabolic profiling of plasma from seven mammalian species for simultaneous environmental chemical surveillance and bioeffect monitoring. |
| Q28394887 | Human biological monitoring of suspected endocrine-disrupting compounds |
| Q63349825 | Identification of Per- and Polyfluoroalkyl Substances in the Cape Fear River by High Resolution Mass Spectrometry and Nontargeted Screening |
| Q37959888 | Immunotoxicity of perfluorinated compounds: recent developments. |
| Q49935950 | Impact of perfluorochemicals on human health and reproduction: a male's perspective |
| Q92633952 | Increased Cardiovascular Risk Associated with Chemical Sensitivity to Perfluoro-Octanoic Acid: Role of Impaired Platelet Aggregation |
| Q36840353 | Influence of salinity and temperature on uptake of perfluorinated carboxylic acids (PFCAs) by hydroponically grown wheat (Triticum aestivum L.). |
| Q36493907 | Influenza vaccine response in adults exposed to perfluorooctanoate and perfluorooctanesulfonate |
| Q36159527 | Level and temporal trend of perfluoroalkyl acids in Greenlandic Inuit |
| Q46632573 | Levels of persistent contaminants in relation to fish consumption among older male anglers in Wisconsin |
| Q36095017 | Longitudinal measures of perfluoroalkyl substances (PFAS) in serum of Gullah African Americans in South Carolina: 2003-2013. |
| Q48377955 | Low-level perfluorooctanoic acid enhances 3 T3-L1 preadipocyte differentiation via altering peroxisome proliferator activated receptor gamma expression and its promoter DNA methylation. |
| Q93018646 | Making the invisible visible: results of a community-led health survey following PFAS contamination of drinking water in Merrimack, New Hampshire |
| Q28383653 | Modeled PFOA exposure and coronary artery disease, hypertension, and high cholesterol in community and worker cohorts |
| Q23915929 | Mortality and cancer incidence in ammonium perfluorooctanoate production workers |
| Q28395753 | No association between perfluoroalkyl chemicals and hypertension in children |
| Q38989466 | Obesogens and male fertility. |
| Q38558478 | Organ-on-a-chip for assessing environmental toxicants |
| Q46353579 | PFCA uptake and translocation in dominant wheat species (Triticum aestivum L.). |
| Q38068391 | PFOS (perfluorooctanesulfonate) in serum is negatively associated with testosterone levels, but not with semen quality, in healthy men. |
| Q89845047 | Per- and polyfluoroalkyl substances and blood pressure in pre-diabetic adults-cross-sectional and longitudinal analyses of the diabetes prevention program outcomes study |
| Q47833635 | Per- and polyfluoroalkyl substances in sera from children 3 to 11 years of age participating in the National Health and Nutrition Examination Survey 2013-2014. |
| Q38530449 | Perfluorinated Alkyl Substances: Emerging Insights Into Health Risks. |
| Q57293921 | Perfluorinated Chemicals as Emerging Environmental Threats to Kidney Health: A Scoping Review |
| Q36023451 | Perfluorinated compounds in relation to birth weight in the Norwegian Mother and Child Cohort Study |
| Q35631579 | Perfluorinated compounds: emerging POPs with potential immunotoxicity |
| Q34275281 | Perfluoroalkyl chemicals and asthma among children 12-19 years of age: NHANES (1999-2008). |
| Q24635118 | Perfluoroalkyl chemicals and elevated serum uric acid in US adults |
| Q35339240 | Perfluoroalkyl substances and time to pregnancy in couples from Greenland, Poland and Ukraine |
| Q28394126 | Perfluorooctanesulfonate Mediates Renal Tubular Cell Apoptosis through PPARgamma Inactivation |
| Q52689096 | Perfluorooctanoic acid (PFOA) exposure promotes proliferation, migration and invasion potential in human breast epithelial cells. |
| Q37374188 | Perfluorooctanoic acid (PFOA) exposures and incident cancers among adults living near a chemical plant |
| Q42832121 | Perfluorooctanoic acid binds to peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation in 3T3-L1 adipocytes |
| Q36261424 | Perfluorooctanoic acid enhances colorectal cancer DLD-1 cells invasiveness through activating NF-κB mediated matrix metalloproteinase-2/-9 expression |
| Q34647222 | Perfluorooctanoic acid exposure and cancer outcomes in a contaminated community: a geographic analysis |
| Q35874820 | Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed community |
| Q35727717 | Perfluorooctanoic acid exposure for 28 days affects glucose homeostasis and induces insulin hypersensitivity in mice |
| Q36185302 | Perfluorooctanoic acid exposure is associated with elevated homocysteine and hypertension in US adults |
| Q41681299 | Perfluorooctanoic acid exposure triggers oxidative stress in the mouse pancreas |
| Q37687025 | Perfluorooctanoic acid induces human Ishikawa endometrial cancer cell migration and invasion through activation of ERK/mTOR signaling |
| Q57213286 | Physicochemical factors controlling the retention and transport of perfluorooctanoic acid (PFOA) in saturated sand and limestone porous media |
| Q38690520 | Physiologically based pharmacokinetic modeling of human exposure to perfluorooctanoic acid suggests historical non drinking-water exposures are important for predicting current serum concentrations |
| Q49644181 | Plasma Concentrations of Per- and Polyfluoroalkyl Substances at Baseline and Associations with Glycemic Indicators and Diabetes Incidence among High-Risk Adults in the Diabetes Prevention Program Trial |
| Q45230914 | Polybrominated diphenyl ethers and perfluoroalkyl substances in serum of pregnant women: levels, correlations, and potential health implications |
| Q36876519 | Positive association between perfluoroalkyl chemicals and hyperuricemia in children |
| Q42680253 | Pregnancy-induced hypertension "probably linked" to PFOA contamination |
| Q77792301 | Preliminary assessment of exposure to persistent organic pollutants among pregnant women in Puerto Rico |
| Q36938040 | Prenatal Exposure to Perfluoroalkyl Substances and Behavioral Development in Children |
| Q35941792 | Prenatal exposure to perfluorooctanoate and risk of overweight at 20 years of age: a prospective cohort study |
| Q52622479 | Priorities for cancer prevention: lifestyle choices versus unavoidable exposures. |
| Q34478572 | Private drinking water wells as a source of exposure to perfluorooctanoic acid (PFOA) in communities surrounding a fluoropolymer production facility |
| Q28384774 | Prostate-specific antigen and perfluoroalkyl acids in the C8 health study population |
| Q37057606 | Recent developments in methods for analysis of perfluorinated persistent pollutants |
| Q36493895 | Reductions in serum lipids with a 4-year decline in serum perfluorooctanoic acid and perfluorooctanesulfonic acid |
| Q36229096 | Relationship of perfluorooctanoic acid exposure to pregnancy outcome based on birth records in the mid-Ohio Valley |
| Q35682907 | Retrospective exposure estimation and predicted versus observed serum perfluorooctanoic acid concentrations for participants in the C8 Health Project |
| Q45376606 | Serum concentrations of perfluorinated alkyl acids and their associations with diet and personal characteristics among Swedish adults |
| Q36939320 | Serum perfluoroalkyl acids concentrations and memory impairment in a large cross-sectional study |
| Q41680536 | Serum perfluorooctanoic acid (PFOA) concentrations in normal and hyperlipidemic female hamsters dosed orally with ammonium perfluorooctanoate (APFO) for up to 30 days |
| Q54993802 | Stochastic Pharmacokinetic-Pharmacodynamic Modeling for Assessing the Systemic Health Risk of Perfluorooctanoate (PFOA). |
| Q42705686 | Structure-activity relations in binding of perfluoroalkyl compounds to human thyroid hormone T3 receptor |
| Q34275367 | The Navigation Guide - evidence-based medicine meets environmental health: integration of animal and human evidence for PFOA effects on fetal growth. |
| Q26851809 | The Navigation Guide - evidence-based medicine meets environmental health: systematic review of human evidence for PFOA effects on fetal growth |
| Q34275302 | The Navigation Guide systematic review methodology: a rigorous and transparent method for translating environmental health science into better health outcomes |
| Q42924277 | The Navigation Guide: systematic review for the environmental health sciences |
| Q46249387 | The PPARα-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions. |
| Q40015587 | The influence of a non-aqueous phase liquid (NAPL) and chemical oxidant application on perfluoroalkyl acid (PFAA) fate and transport |
| Q51303543 | The modifying effect of vitamin C on the association between perfluorinated compounds and insulin resistance in the Korean elderly: a double-blind, randomized, placebo-controlled crossover trial. |
| Q43955348 | The role of number of meals, coffee intake, salt and type of cookware on colorectal cancer development in the context of the Mediterranean diet |
| Q52690564 | The role of pollutants in type 2 diabetes mellitus (T2DM) and their prospective impact on phytomedicinal treatment strategies. |
| Q36115374 | Thyroid function and perfluoroalkyl acids in children living near a chemical plant |
| Q36602294 | Toxicological function of adipose tissue: focus on persistent organic pollutants. |
| Q37072627 | Ulcerative colitis and perfluorooctanoic acid (PFOA) in a highly exposed population of community residents and workers in the mid-Ohio valley |
| Q36433117 | Within- and between-group regression for improving the robustness of causal claims in cross-sectional analysis |
Search more.